[1]
Schmidt, C. et al. 2024. The utility of procalcitonin as a biomarker of hospital-acquired infection in severe COVID-19. African Journal of Thoracic and Critical Care Medicine. 30, 4 (Dec. 2024), e1617. DOI:https://doi.org/10.7196/AJTCCM.2024.v30i4.1617.